BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 35871019)

  • 21. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).
    Mitchell JW; Noble A; Baker G; Batchelor R; Brigo F; Christensen J; French J; Gil-Nagel A; Guekht A; Jette N; Kälviäinen R; Leach JP; Maguire M; O'Brien T; Rosenow F; Ryvlin P; Tittensor P; Tripathi M; Trinka E; Wiebe S; Williamson PR; Marson T
    Trials; 2022 Nov; 23(1):943. PubMed ID: 36397081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COS-Speech: protocol to develop a core outcome set for dysarthria after stroke for use in clinical practice and research.
    Mitchell C; Bowen A; Conroy P; Whelan BM; Wallace SJ; Dancer A; Woodward-Nutt K; Kirkham JJ
    Trials; 2023 Jan; 24(1):57. PubMed ID: 36698201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.
    Potter S; Avery K; Ahmed R; de Boniface J; Chatterjee S; Dodwell D; Dubsky P; Iwata H; Jiang M; Lee HB; MacKenzie M; Poulakaki F; Richardson AL; Sepulveda K; Spillane A; Thompson AM; Werutsky G; Wright JL; Zdenkowski N; Cowan K; McIntosh S
    BMJ Open; 2024 Apr; 14(4):e084488. PubMed ID: 38643011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Core outcomes in periodontal trials: study protocol for core outcome set development.
    Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
    Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
    Karnik NS; Campbell CI; Curtis ME; Fiellin DA; Ghitza U; Hefner K; Hser YI; McHugh RK; Murphy SM; McPherson SM; Moran L; Mooney LJ; Wu LT; Shmueli-Blumberg D; Shulman M; Schwartz RP; Stephens KA; Watkins KE; Marsden J
    Trials; 2021 Jan; 22(1):102. PubMed ID: 33509278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
    Simpson RC; Kirtschig G; Selk A; von Seitzberg S; Vittrup G; Bissonnette I; Kottner J; Lanthier J; Stanton C; Foster D; Promm M; Augenti A; Lauretti S; Thomas KS;
    Br J Dermatol; 2023 Apr; 188(5):628-635. PubMed ID: 36702803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
    Jacobson ME; Rick JW; Gerbens LAA; Baghoomian W; Gould LJ; Marzano AV; Chen DM; Oakes DL; Dissemond J; Yamamoto T; Shinkai K; Nolan B; Lobato D; Thomas KS; Ortega-Loayza AG;
    Br J Dermatol; 2024 Feb; 190(3):392-401. PubMed ID: 37952167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Iyengar S; Williamson PR; Schmitt J; Johannsen L; Maher IA; Sobanko JF; Cartee TV; Schlessinger D; Poon E; Alam M
    Trials; 2016 Sep; 17(1):429. PubMed ID: 27580586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum.
    Rick J; Gould LJ; Marzano AV; Garg A; Chen D; Oakes DL; Dissemond J; Herfarth H; Friedman MA; Alavi A; Yamamoto T; Gerbens LAA; Thomas KS; Ortega-Loayza AG
    Arch Dermatol Res; 2023 May; 315(4):983-988. PubMed ID: 36305958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.
    Potter BK; Hutton B; Clifford TJ; Pallone N; Smith M; Stockler S; Chakraborty P; Barbeau P; Garritty CM; Pugliese M; Rahman A; Skidmore B; Tessier L; Tingley K; Coyle D; Greenberg CR; Korngut L; MacKenzie A; Mitchell JJ; Nicholls S; Offringa M; Schulze A; Taljaard M;
    Trials; 2017 Dec; 18(1):603. PubMed ID: 29258568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.
    Smith TO; Hawker GA; Hunter DJ; March LM; Boers M; Shea BJ; Christensen R; Guillemin F; Terwee CB; Williamson PR; Dodd S; Roos EM; Loeser RF; Schnitzer TJ; Kloppenburg M; Neogi T; Ladel CH; Kalsi G; Kaiser U; Buttel TW; Ashford AE; Mobasheri A; Arden NK; Tennant A; Hochberg MC; de Wit M; Tugwell P; Conaghan PG
    J Rheumatol; 2019 Aug; 46(8):981-989. PubMed ID: 30647185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creation of a core outcome set for clinical trials of people with shoulder pain: a study protocol.
    Gagnier JJ; Page MJ; Huang H; Verhagen AP; Buchbinder R
    Trials; 2017 Jul; 18(1):336. PubMed ID: 28728574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.
    El Karim IA; Duncan HF; Cushley S; Nagendrababu V; Kirkevang LL; Kruse C; Chong BS; Shah PK; Lappin M; McLister C; Lundy FT; Clarke M
    Trials; 2021 Nov; 22(1):812. PubMed ID: 34789318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.